Gateway 2011: WellSpring Pharmaceutical Canada Corp - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2011: WellSpring Pharmaceutical Canada Corp



Your online Gateway to WellSpring Pharmaceutical Canada Corp in 2011

400 Iroquois Shore Road,
Oakville Ontario L6H 1M5 Canada
1-866-337-4500
Fax: 905-337-7239
http://www.wellspringcmo.com

About WellSpring Pharmaceutical Canada Corp

With WellSpring Pharmaceutical Contract Services our ability is your solution for manufacturing and packaging of virtually all finished non-sterile, solid and semi-solid dose products. We also provide clinical manufacturing, over-encapsulation, labeling, packaging, storage, distribution and returned goods management to support our clients’ most complex clinical trial requirements.


 


Our capabilities include blending, granulation, tablet compression, encapsulation, film coating, and topicals and liquids processing. Extensive packaging capabilities enable tablets or capsules to be bottled or blister-sealed and topical products can be supplied in jars and tubes. Our facility and quality systems have been successfully inspected by FDA and Health Canada.

Please visit WellSpring Pharmaceutical for manufacturing, packaging, analytical and distribution services for clinical and commercial supplies.  Contact us to arrange a convenient time to discuss how we can provide contract services supply chain solutions for virtually all finished non-sterile, liquids, semi-solids  and solid dosage form products.  WellSpring’s outstanding customer service and flexibility will ensure your supply chain needs are met.

 

New Products
and Releases

Brochure

 

For more information:

info@wellspringcmo.com

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
6%
All of the above.
42%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here